Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $15.66 million. The enterprise value is $8.75 million.

Market Cap	15.66M
Enterprise Value	8.75M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

PCSA has 50.35 million shares outstanding. The number of shares has increased by 284.85% in one year.

Current Share Class	50.35M
Shares Outstanding	50.35M
Shares Change (YoY)	+284.85%
Shares Change (QoQ)	+63.43%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	11.62%
Float	42.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.05
P/TBV Ratio	2.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.00.

Current Ratio	3.45
Quick Ratio	3.36
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -212.38% and return on invested capital (ROIC) is -131.95%.

Return on Equity (ROE)	-212.38%
Return on Assets (ROA)	-102.62%
Return on Invested Capital (ROIC)	-131.95%
Return on Capital Employed (ROCE)	-212.16%
Revenue Per Employee	n/a
Profits Per Employee	-$1.29M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.26% in the last 52 weeks. The beta is 1.52, so PCSA's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	-76.26%
50-Day Moving Average	0.25
200-Day Moving Average	0.34
Relative Strength Index (RSI)	51.85
Average Volume (20 Days)	24,573,674

Short Selling Information

The latest short interest is 13.76 million, so 27.32% of the outstanding shares have been sold short.

Short Interest	13.76M
Short Previous Month	2.66M
Short % of Shares Out	27.32%
Short % of Float	32.29%
Short Ratio (days to cover)	0.65

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.96M
Pretax Income	-12.88M
Net Income	-12.88M
EBITDA	-12.96M
EBIT	-12.96M
Earnings Per Share (EPS)	-$1.63

Balance Sheet

The company has $6.94 million in cash and $25,584 in debt, giving a net cash position of $6.91 million or $0.14 per share.

Cash & Cash Equivalents	6.94M
Total Debt	25,584
Net Cash	6.91M
Net Cash Per Share	$0.14
Equity (Book Value)	6.11M
Book Value Per Share	0.15
Working Capital	5.08M

Cash Flow

In the last 12 months, operating cash flow was -$10.85 million and capital expenditures -$3,244, giving a free cash flow of -$10.85 million.

Operating Cash Flow	-10.85M
Capital Expenditures	-3,244
Free Cash Flow	-10.85M
FCF Per Share	-$0.22

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-284.85%
Shareholder Yield	-284.85%
Earnings Yield	-82.27%
FCF Yield	-69.32%

Analyst Forecast

The average price target for PCSA is $1.00, which is 221.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$1.00
Price Target Difference	221.54%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 22, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Jan 22, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1